EP-1242

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEP-1242
Drug Alias NameEP-1242
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFibrinogen modulators
TargetsFibrinogen
Therapy Area/IndicationsVenous ThrombosisAtherosclerosisPulmonary Embolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisAtherosclerosisPulmonary Embolism

Other Information

ATC CodeN/A
Related LinksN/A